Literature DB >> 16906453

Calculation of the penetration depth of X-rays in intact pharmaceutical film-coated tablets by microdiffractometry.

Hiroyuki Yamada1, Raj Suryanarayanan.   

Abstract

PURPOSE: (i) Develop a method to calculate the penetration depth of X-rays in intact film-coated tablets, and validate it using model bilayer tablets. (ii) Characterize the physical form of drug in intact pharmaceutical film-coated tablets by XRD.
MATERIALS AND METHODS: An equation for the calculation of the penetration depth of X-rays, as a function of the incident angle, was derived. Model bilayer tablets were prepared to validate the calculation method. The upper layer of the tablets consisted only of microcrystalline cellulose, while the lower layer was a mixture of cerium oxide (10% w/w), blue dye (5% w/w) and microcrystalline cellulose. The total tablet thickness was 3,500 microm, with the upper layer thickness ranging from 200 to 700 microm. The diffracted intensity of a cerium oxide peak in the lower layer was determined using a microdiffractometer system (CuKalpha radiation) with a two-dimensional area detector. The calculated penetration depth of X-rays was compared with that determined by XRD. After validation of the XRD method, commercial ibuprofen tablets were characterized.
RESULTS: The penetration depth calculated by the method developed in this study was, in general, in good agreement with that determined experimentally by XRD. In commercial ibuprofen tablets, the coating material exhibited peaks due to TiO2 (25.4 degrees 2 theta) and Fe2O3 (33.3 degrees). However, these did not interfere with the characteristic peak of ibuprofen (22.2 degrees).
CONCLUSION: We developed a method for calculation of penetration depth of X-rays in film-coated tablets and validated it using the model bilayer tablets. This method enables the characterization of the active pharmaceutical ingredient in different regions (at different depths) of the film-coated tablet. Since the technique is nondestructive, the same tablet can be repeatedly analyzed during stability studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16906453     DOI: 10.1007/s11095-006-9070-x

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Quantitative determination of polymorphic composition in intact compacts by parallel-beam X-ray powder diffractometry.

Authors:  Wenjin Cao; Simon Bates; Garnet E Peck; Peter L D Wildfong; Zhihui Qiu; Kenneth R Morris
Journal:  J Pharm Biomed Anal       Date:  2002-11-07       Impact factor: 3.935

2.  Investigation of solid-state reactions using variable temperature X-ray powder diffractometry. II. Aminophylline monohydrate.

Authors:  Suneel K Rastogi; Marek Zakrzewski; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

3.  Quantification of crystalline forms in active pharmaceutical ingredient and tablets by X-ray powder diffraction.

Authors:  V Brett Cooper; Gareth E S Pearce; Catherine R Petts
Journal:  J Pharm Pharmacol       Date:  2003-09       Impact factor: 3.765

4.  Influence of processing-induced phase transformations on the dissolution of theophylline tablets.

Authors:  Smita Debnath; Raj Suryanarayanan
Journal:  AAPS PharmSciTech       Date:  2004-02-12       Impact factor: 3.246

5.  Solid state NMR and DSC methods for quantifying the amorphous content in solid dosage forms: an application to ball-milling of trehalose.

Authors:  R Lefort; A De Gusseme; J-F Willart; F Danède; M Descamps
Journal:  Int J Pharm       Date:  2004-08-06       Impact factor: 5.875

6.  Investigation of solid-state reactions using variable temperature X-ray powder diffractrometry. I. Aspartame hemihydrate.

Authors:  S Rastogi; M Zakrzewski; R Suryanarayanan
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

7.  Effects of the mechanical energy of multi-tableting compression on the polymorphic transformations of chlorpropamide.

Authors:  M Otsuka; T Matsumoto; N Kaneniwa
Journal:  J Pharm Pharmacol       Date:  1989-10       Impact factor: 3.765

8.  Quantitative analysis of crystalline pharmaceuticals in powders and tablets by a pattern-fitting procedure using X-ray powder diffraction data.

Authors:  S Yamamura; Y Momose
Journal:  Int J Pharm       Date:  2001-01-16       Impact factor: 5.875

9.  Polymorphism in anhydrous theophylline--implications on the dissolution rate of theophylline tablets.

Authors:  N V Phadnis; R Suryanarayanan
Journal:  J Pharm Sci       Date:  1997-11       Impact factor: 3.534

10.  Use of glancing angle X-ray powder diffractometry to depth-profile phase transformations during dissolution of indomethacin and theophylline tablets.

Authors:  Smita Debnath; Paul Predecki; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.